Genethon’s gene therapy for rare liver disease shows promising early-stage results Therapeutics In Genethon’s Thursday announcement, the company claimed the results are the first clinical demonstration of the efficacy of gene therapy in a metabolic disease of the liver. Read more August 18, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2020/11/Viking-Therapeutics’-NASH-Therapy-Shows-Major-Reduction-of-Liver-Fat-and-LDL-Cholesterol-BioSpace-11-19-20.jpeg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-08-18 08:55:472023-08-18 10:35:25Genethon’s gene therapy for rare liver disease shows promising early-stage results
